Overview

Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection

Status:
Recruiting
Trial end date:
2021-01-22
Target enrollment:
Participant gender:
Summary
The aim of this study is to test whether Traditional Chinese Medicines (TCMs) are effective and safe for treating COVID-19 infection. After the enrolment of approximately 30 subjects, the recruitment will be paused, and planned interim analysis will be performed to preliminarily investigate the efficacy and safety of TCMs in patients infected with COVID-19.
Phase:
N/A
Details
Lead Sponsor:
Beijing 302 Hospital
Treatments:
Antiviral Agents
Interferon-alfa-1b
Interferon-alpha
Interferons
Lopinavir
Ritonavir